11 hours NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy Zacks
Novo Nordisk stock gains 3% as analysts at UBS upgrade the company’s rating from Neutral to Buy based on strong brand recognition of Ozempic and Wegovy.
XNovo Nordisk stock gains 3% as analysts at UBS upgrade the company’s rating from Neutral to Buy based on strong brand recognition of Ozempic and Wegovy.
X